MTIM
PBYI icon

Marathon Trading Investment Management’s Puma Biotechnology PBYI Stock Holding History

Marathon Trading Investment Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,236
Closed -$46.4K – 324
2024
Q2 		$46.4K Sell
14,236
-56,064
-80% -$246K ﹤0.01% 252
2024
Q1 		$373K Buy
+70,300
New +$379K 0.03% 211

Other funds holding PBYI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Marathon Trading Investment Management's PBYI Position: Q3 2024 in Review

Marathon Trading Investment Management sold out of Puma Biotechnology (PBYI) in Q3 2024, closing a stake of 14,236 shares — an estimated $46.4K sold.

Marathon Trading Investment Management first reported a position in PBYI in Q1 2024 and held it in 2 quarters. The position peaked at $373K in Q1 2024. 100 funds tracked by Wall St. Rank hold PBYI as of Q3 2024.

  • Marathon Trading Investment Management reported no remaining Puma Biotechnology position as of Q3 2024 after selling out during the quarter.
  • Marathon Trading Investment Management sold 14,236 Puma Biotechnology shares in Q3 2024, an estimated $46.4K.
  • Marathon Trading Investment Management first reported a position in Puma Biotechnology in Q1 2024 and held it in 2 quarters.
  • Marathon Trading Investment Management's Puma Biotechnology position peaked at $373K in Q1 2024.
  • 100 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2024.

Based on Marathon Trading Investment Management's 13F filing for Q3 2024, filed 7 Nov 2024.